This is a demo store. No orders will be fulfilled.

Solanezumab (anti-Amyloid Beta) - Primary antibody, specific to APP, >95%, high purity, Human IgG1, BINDING AGENT of Beta amyloid A4 protein binding agent, BINDING AGENT of Beta amyloid A4 protein binding agent

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab175657
Grouped product items
SKU Size
Availability
Price Qty
Ab175657-100μg
100μg
10
$59.90
Ab175657-1mg
1mg
4
$279.90
Ab175657-5mg
5mg
1
$739.90
Ab175657-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,189.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Solanezumab (anti-Amyloid Beta) - Primary antibody, specific to APP, >95%, high purity, Human IgG1, BINDING AGENT of Beta amyloid A4 protein binding agent
Synonyms A4_HUMAN antibody | AAA antibody | ABETA antibody | ABPP antibody | AD1 antibody | AICD-50 antibody | AICD-57 antibody | AICD-59 antibody | AID(50) antibody | AID(57) antibody | AID(59) antibody | Alzheimer disease amyloid protein antibody | amyloid beta
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity APP
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type BINDING AGENT
Mechanism of action BINDING AGENT of Beta amyloid A4 protein binding agent
Product Description

Solanezumab (anti-Amyloid Beta) is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab (anti-Amyloid Beta) has the potential for the research of Alzheimer’s disease.

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 27.6 kDa (Light Chain) & 53.3 kDa (Heavy Chain), under reducing conditions; 181.1 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95%
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 955085-14-0

Associated Targets(Human)

APP Tclin Amyloid-beta A4 protein (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Solanezumab (anti-Amyloid Beta) (Ab175657) - ELISA
Immobilized hu-Amyloid β-Peptide (1-40) at 2.0 μg/mL can bind Solanezumab (anti-Amyloid Beta) (Ab175657) with the EC₅₀ of 541.9 ng/mL.


Solanezumab (anti-Amyloid Beta) (Ab175657) - SEC
The purity of Solanezumab (anti-Amyloid Beta) (Ab175657) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0303708 Certificate of Analysis Mar 26, 2024 Ab175657
ZJ24F0303707 Certificate of Analysis Mar 26, 2024 Ab175657
ZJ24F0303706 Certificate of Analysis Mar 26, 2024 Ab175657

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.